Etravirine
Intelence (etravirine) is a small molecule pharmaceutical. Etravirine was first approved as Intelence on 2008-01-18. It is used to treat HIV infections in the USA. It has been approved in Europe to treat HIV infections.
| Trade Name | Intelence |
|---|---|
| Common Name | Etravirine |
| Indication | hiv infections |
| Drug Class | Antivirals: non-nucleoside reverse transcriptase inhibitors, not benzoxazinone derivatives |
